Clinical Trials

489 articles

Participating in clinical trials can give you access to the latest treatments for pancreatic cancer.

Research
June 14, 2019 • 2 Min

Testing a New Drug to Attack Pancreatic Tumor Blood Vessels

A clinical trial is testing a new drug combination that damages the tumor blood vessels and allows chemotherapy drugs to enter the tumor.

Research
December 13, 2019 • 3 Min

Testing Treatment Combinations to Make Surgery More Effective

Can losartan (a high blood pressure drug) and immunotherapy combined with standard chemotherapy and radiation be an effective combination against pancreatic cancer?

Disease Management
April 21, 2021 • 4 Min

Pancreatic Cancer Patients Have a Role in Treatment Choices

Pancreatic Cancer UK’s Peter De Rosa explains how patient-reported outcome measures can help direct treatment choices and supportive care.

Research
September 5, 2017 • 4 Min

New Cancer Stem Cell Pathway Drug May Change Standard of Care

Dr. Tanios Bekaii-Saab is testing a new drug that works on pancreatic cancer stem cells to make chemotherapy more effective.

Research
January 5, 2021 • 1 Min

Comparing Effectiveness of Chemotherapy Before and After Surgery

Is chemotherapy before and after pancreatic cancer surgery more effective than just chemotherapy after surgery?

Research
June 21, 2021 • 3 Min

CRISPR-Engineered Immunotherapy for Metastatic GI Tract Cancers

CRISPR technology is used as part of an immunotherapy clinical trial for metastatic pancreatic cancer and other GI cancers.

Research
September 8, 2022 • 2 Min

Managing Metastatic Pancreatic Cancer with Chemotherapy and Diet

A new clinical trial looks at a special diet that tries to curb a patient’s metabolism to slow cancer growth during chemotherapy.

Research
December 16, 2022 • 4 Min

NAPOLI-3 Trial Meets Primary Endpoint in Metastatic Disease

Dr. Tanios Bekaii-Saab explains the early positive results from the NAPOLI-3 clinical trial, testing the NALIRIFOX combination.

Research
May 15, 2024 • 2 Min

A New Triple Combination for Tumors with BRCA1/2 or PALB2 Mutations

A clinical trial is comparing a two-drug combination with a three-drug combination to see which works better for genetic mutations.

Research
November 21, 2016 • 4 Min

Immunotherapy Treatments Provide Hope to Pancreatic Cancer Patients

Dr. Robert Vonderheide of the Abramson Cancer Center at the University of Pennsylvania describes immunotherapy trials for pancreatic cancer.

News
October 14, 2016 • 5 Min

This Is What It’s Like To Live With Pancreatic Cancer

Anne Glauber recounts her treatment for pancreatic cancer for Prevention magazine and offers insights on embracing each day and living it to its fullest.

Research
April 13, 2017 • 4 Min

Testing Vitamin C as a Cancer Killer

Lewis Cantley’s team is starting clinical trials of vitamin C to gain more information about its role in stopping cancer.

Research
April 18, 2022 • 6 Min

New Immunotherapy Strategy Aimed at High-Risk Population

Dr. Neeha Zaidi is the lead investigator of an immunotherapy trial using a vaccine for people at high risk for pancreatic cancer.

Research
May 26, 2022 • 3 Min

Chemotherapy-Radiation Combination for Pancreatic Cancer in the Liver

Can targeted radiation disrupt tumor growth in the liver of advanced pancreatic cancer patients with BRCA2 and PALB2 mutations?

Research
June 22, 2023 • 2 Min

Targeted Therapy for Cancers Carrying the PALB2 Mutation

Researchers are testing a type of targeted therapy called a PARP inhibitor for cancers carrying the PALB2 mutation.